A.R.T. Advisors’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-56,655
Closed -$723K 1571
2019
Q3
$723K Buy
56,655
+34,500
+156% +$497K 0.04% 704
2019
Q2
$376K Sell
22,155
-33,000
-60% -$567K 0.02% 864
2019
Q1
$992K Buy
55,155
+39,002
+241% +$674K 0.06% 487
2018
Q4
$205K Sell
16,153
-6,100
-27% -$102K 0.01% 1062
2018
Q3
$477K Buy
+22,253
New +$474K 0.02% 874
2018
Q1
Sell
-34,493
Closed -$655K 1662
2017
Q4
$655K Buy
34,493
+300
+0.9% +$5.6K 0.03% 782
2017
Q3
$631K Buy
+34,193
New +$592K 0.03% 733
2016
Q3
Sell
-12,201
Closed -$329K 954
2016
Q2
$329K Sell
12,201
-11,800
-49% -$266K 0.02% 943
2016
Q1
$450K Buy
24,001
+1,400
+6% +$26.7K 0.02% 897
2015
Q4
$699K Buy
22,601
+9,542
+73% +$290K 0.03% 722
2015
Q3
$279K Buy
+13,059
New +$410K 0.01% 1063
2015
Q2
Sell
-43,057
Closed -$1.35M 1615
2015
Q1
$1.35M Buy
+43,057
New +$1.46M 0.05% 546

Other funds holding MGNX

A.R.T. Advisors's MGNX Position: Q4 2019 in Review

A.R.T. Advisors sold out of MacroGenics (MGNX) in Q4 2019, closing a stake of 56,655 shares — an estimated $723K sold.

A.R.T. Advisors first reported a position in MGNX in Q1 2015 and held it in 12 quarters. The position peaked at $1.35M in Q1 2015. 124 funds tracked by Wall St. Rank hold MGNX as of Q4 2019.

  • A.R.T. Advisors reported no remaining MacroGenics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 56,655 MacroGenics shares in Q4 2019, an estimated $723K.
  • A.R.T. Advisors first reported a position in MacroGenics in Q1 2015 and held it in 12 quarters.
  • A.R.T. Advisors's MacroGenics position peaked at $1.35M in Q1 2015.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.